Suchergebnisse - "Tabak, Fehmi"

PubPharm (19)

1

Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta

enthalten in: Journal of viral hepatitis | 2020

von Wranke, A. | Hardtke, S. | Heidrich, B. | +15

2

Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B

enthalten in: Journal of viral hepatitis | 2019

von van Campenhout, M. | Rijckborst, V. | Brouwer, W. | +10

3

Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a : Week 120 Analysis

enthalten in: Digestive diseases and sciences | 2018

von Ahn, S. | Marcellin, P. | Ma, X. | +19

ErratumIn: Dig Dis Sci. 2018 Oct 15;:. - PMID 30324553

4

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

enthalten in: Gastroenterology | 2016

von Marcellin, P. | Ahn, S. | Ma, X. | +28

CommentIn: Gastroenterology. 2016 Jan;150(1):32-4. - PMID 26615120

5

Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2015

von Keskin, O. | Wedemeyer, H. | Tüzün, A. | +13

CommentIn: Clin Gastroenterol Hepatol. 2015 Dec;13(13):2350-2. - PMID 26254201

6

Hepatic apoptotic markers are not predictors for the virological response to interferon-based therapy in chronic hepatitis C patients

enthalten in: European journal of gastroenterology & hepatology | 2015

von Ozaras, R. | Tahan, V. | Ozbay, G. | +11

7

Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B : A multicenter randomized trial (ARES study)

enthalten in: Hepatology (Baltimore, Md.) | 2015

von Brouwer, W. | Xie, Q. | Sonneveld, M. | +17

CommentIn: Hepatology. 2015 May;61(5):1459-61. - PMID 25645624

8

Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta

enthalten in: Hepatology (Baltimore, Md.) | 2014

von Heidrich, B. | Yurdaydın, C. | Kabaçam, G. | +14

9

Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a

enthalten in: Journal of hepatology | 2012

von Rijckborst, V. | Hansen, B. | Ferenci, P. | +11

10

Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b : relation to response and HBV genotype

enthalten in: Antiviral therapy | 2012

von Sonneveld, M. | Rijckborst, V. | Cakaloglu, Y. | +8